{"id":6209,"date":"2024-10-19T22:07:49","date_gmt":"2024-10-19T13:07:49","guid":{"rendered":"https:\/\/www.hiro-clinic.or.jp\/nippt\/novaseq-high-throughput-genomic-analysis\/"},"modified":"2024-10-23T12:57:50","modified_gmt":"2024-10-23T03:57:50","slug":"novaseq-high-throughput-genomic-analysis","status":"publish","type":"post","link":"https:\/\/www.hiro-clinic.or.jp\/nippt\/novaseq-high-throughput-genomic-analysis\/?lang=en","title":{"rendered":"What is Novaseq, the most advanced"},"content":{"rendered":"\n

NovaSeq is the leading model for next-generation sequencing, offering a wide range of data throughput options and used for analysis of large sample volumes and comprehensive analysis of complex genomes<\/strong>.<\/p>\n\n\n\n\n\n\n

1. main features of NovaSeq<\/h3>\n\n\n\n

ultrahigh throughput<\/h4>\n\n\n\n

The most important feature of the NovaSeq is its extremely high data throughput<\/strong>: it can generate up to 6 Tb<\/mark> (terabytes)<\/strong> or more of data in a single run, making it possible to analyze hundreds of<\/strong> whole human genomes simultaneously. This is by far the most data that can be generated compared to other Illumina sequencers.<\/p>\n\n\n\n

Flexible throughput options<\/h4>\n\n\n\n

NovaSeq offers a variety of Flow Cell options<\/strong>, allowing you to tailor data throughput to the size of your project. This allows for small to very large sequencing projects<\/strong>. The following four flow cell types are available<\/p>\n\n\n\n

    \n
  1. S1 Flow Cell<\/strong>: For small to medium size projects. Generates up to 770 Gb of data.<\/li>\n\n\n\n
  2. S2 Flow Cell<\/strong>: For mid-size projects. Generates up to 1.6 Tb of data.<\/li>\n\n\n\n
  3. S4 Flow Cell<\/strong>: For large scale projects. Generates up to 6 Tb of data.<\/li>\n\n\n\n
  4. SP Flow Cell<\/strong>: Minimum throughput option, suitable for cost-effective projects.<\/li>\n<\/ol>\n\n\n\n

    High-speed sequencing<\/h4>\n\n\n\n

    NovaSeq is capable of extremely fast data generation. Even with paired-end 150<\/strong> base pair<\/strong> (150 bp \u00d7 2) reads, large amounts of data can be generated within 1-2 days, enabling rapid results for time-consuming whole genome analysis and large RNA sequencing<\/strong> projects. The system can also be used to generate large amounts of data within one to two days.<\/p>\n\n\n\n

    Illumina’s innovative technologies (SBS technology and X-channel chemistry)<\/h4>\n\n\n\n
      \n
    • Sequencing Bisynthesis (SBS) Technology<\/strong>:
      NovaSeq, like all Illumina sequencers, utilizes SBS technology. This technology detects and determines DNA sequences in real time as fluorescently labeled nucleotides are incorporated one nucleotide at a time. Highly accurate and high-throughput data generation is possible.<\/li>\n\n\n\n
    • X-Channel Chemistry<\/strong>:
      NovaSeq uses Illumina’s latest X-channel chemistry<\/strong>, which is even faster and more efficient than traditional 2-channel chemistry. This technology significantly increases sequencing speed and generates vast amounts of data in a very short period of time.<\/li>\n<\/ul>\n\n\n\n

      Dual indexing option<\/h4>\n\n\n\n

      NovaSeq supports dual indexing<\/strong>, allowing you to sequence thousands of samples<\/strong> simultaneously in a single run. This allows multiple samples to be processed efficiently, saving significant time and cost.<\/p>\n\n\n\n\n\n\n

      2. applications of NovaSeq<\/h3>\n\n\n\n

      NovaSeq is widely used for very large sequencing projects and commercial sequencing services<\/strong> requiring high throughput. The main applications are as follows<\/p>\n\n\n\n

      2.1 Whole genome sequencing (WGS)<\/h4>\n\n\n\n

      The NovaSeq is used as the standard model for human whole genome sequencing<\/strong> and is capable of whole genome analysis of large populations. Suitable for individual genome profiling and disease-related large-scale genomic variation analysis, it can cover the entire genome of multiple individuals in a single run, making it particularly suitable for cancer research<\/strong> and population genomics<\/strong> projects.<\/p>\n\n\n\n

      2.2 Transcriptome analysis (RNA-seq)<\/h4>\n\n\n\n

      NovaSeq is also ideal for transcriptome analysis in gene expression analysis<\/strong> using RNA sequencing (RNA-seq)<\/strong>, as it can acquire large data sets in a short period of time. RNA profiling of tens to hundreds of samples can be performed at once.<\/p>\n\n\n\n

      2.3 Exome sequencing<\/h4>\n\n\n\n

      Exome sequ<\/strong>encing targets the coding regions of genes for comprehensive analysis of disease-associated genetic variation, and NovaSeq can perform exome sequencing of thousands of samples in parallel, making it suitable for large-scale genetic variation projects.<\/p>\n\n\n\n

      2.4 Multiplex target sequencing<\/h4>\n\n\n\n

      The NovaSeq is also used for targeted sequencing<\/strong>, such as in cancer gene panels and genetic disease analysis panels<\/strong>, to detect a wide range of genetic variants. It is also cost-effective because it efficiently analyzes multiplexed samples.<\/p>\n\n\n\n

      2.5 Large-scale metagenomic analysis<\/h4>\n\n\n\n

      NovaSeq is also used for metagenomic analysis<\/strong> (environmental DNA analysis) to analyze the diversity of microbial communities in the environment, monitor pathogens, and study evolution.<\/p>\n\n\n

      \n
      \"\u89aa\u5b50\u9451\u5b9a\u3000NIPPT\u3000DNA\u9451\u5b9a\u3000\u7cbe\u6db2\"<\/figure><\/div>\n\n\n\n\n\n

      3. advantages of NovaSeq<\/h3>\n\n\n\n
        \n
      1. Very high throughput<\/strong>: With the ability to generate up to 6 Tb of data, large projects and thousands of samples can be analyzed quickly.<\/li>\n\n\n\n
      2. Rapid data acquisition<\/strong>: NovaSeq is extremely fast and can generate large amounts of sequencing data within one to two days, enabling rapid results for even large, time-consuming analysis projects.<\/li>\n\n\n\n
      3. Increased cost efficiency<\/strong>: High throughput and the ability to process large volumes of samples reduces the cost per sample, making it very efficient in large studies.<\/li>\n\n\n\n
      4. Wide range of<\/strong> applications: Whole genome analysis, RNA sequencing, exome analysis, targeted sequencing, metagenome analysis, etc.<\/li>\n<\/ol>\n\n\n\n\n\n\n

        summary<\/h3>\n\n\n\n

        NovaSeq<\/strong> is Illumina’s most powerful next-generation sequencer, with extremely high data throughput and flexible flow cell options, making it ideal for large-scale genome analysis projects<\/strong>. It is widely used by research institutions and commercial sequencing services that require high throughput analysis<\/strong> for whole genome sequencing, exome analysis, and RNA sequencing, as it can analyze large numbers of samples simultaneously and generate vast amounts of data in a short time.<\/p>\n","protected":false},"excerpt":{"rendered":"

        NovaSeq is the leading model for next-generation sequencing, offering a wide range of…<\/p>\n","protected":false},"author":5,"featured_media":3147,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[33],"tags":[73,69,39,74,70,76,72],"class_list":{"0":"post-6209","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetic-testing-en","8":"tag-dna_profiling-en","9":"tag-dna_test-en","10":"tag-expert-en","11":"tag-accuracy-en","12":"tag-result-en","13":"tag-genetic_testing-en","14":"tag-analysis-en","15":"article"},"acf":[],"_links":{"self":[{"href":"https:\/\/www.hiro-clinic.or.jp\/nippt\/wp-json\/wp\/v2\/posts\/6209","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hiro-clinic.or.jp\/nippt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hiro-clinic.or.jp\/nippt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hiro-clinic.or.jp\/nippt\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hiro-clinic.or.jp\/nippt\/wp-json\/wp\/v2\/comments?post=6209"}],"version-history":[{"count":2,"href":"https:\/\/www.hiro-clinic.or.jp\/nippt\/wp-json\/wp\/v2\/posts\/6209\/revisions"}],"predecessor-version":[{"id":6218,"href":"https:\/\/www.hiro-clinic.or.jp\/nippt\/wp-json\/wp\/v2\/posts\/6209\/revisions\/6218"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.hiro-clinic.or.jp\/nippt\/wp-json\/wp\/v2\/media\/3147"}],"wp:attachment":[{"href":"https:\/\/www.hiro-clinic.or.jp\/nippt\/wp-json\/wp\/v2\/media?parent=6209"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hiro-clinic.or.jp\/nippt\/wp-json\/wp\/v2\/categories?post=6209"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hiro-clinic.or.jp\/nippt\/wp-json\/wp\/v2\/tags?post=6209"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}